EMD Serono, the biopharmaceutical business of Merck KGaA, has appointed Craig Millian as senior vice president (SVP), neurology and immunology. Mr. Millian most recently served as SVP, head of US fertility and endocrinology at EMD Serono. In his new role, he will lead the strategic direction of the company’s US neurology and immunology franchise.
Mr. Millian joined EMD Serono in 2010 to lead the fertility and endocrinology marketing team. He previously served as vice president, commercial at Vertex Pharmaceuticals. Prior to Vertex, he held commercial leadership roles at Pfizer and Sanofi.
Drew Young, who previously served as SVP, neurology and immunology for EMD Serono, has recently been appointed to a new position within Merck KGaA. He will serve as general manager and managing director, Merck KGaA, Darmstadt, Germany, Biopharma, Australia & New Zealand, effective on September 1, 2016. Mr. Young joined EMD Serono in June 2014 and had a positive impact on the company’s neurology and immunology performance.
Source: EMD Serono